ALR Technologies Inc. (ALRTF)
ALR Technologies Inc. operates in the Medical - Devices industry of the Healthcare sector, headquartered in Singapore, VA, SG. The stock last traded at $0.02, up 9.96% on the session, giving a market capitalisation of $11.6M. On trailing twelve-month figures it carries a trailing P/E of -1.35, a net margin of -159306.4%. Its beta of 2.32 implies it has historically moved more than the broad market.
ALR Technologies Inc. is a data management company dedicated to creating and providing diabetes care solutions for both human and animal health sectors across the United States. Central to its offerings is the comprehensive Diabetes Management System. This system facilitates data collection, provides predictive A1C analysis, offers recommendations for insulin dosage adjustments, tracks performance, enables remote patient monitoring, and supplies essential diabetes testing materials. The company also markets Continuous Glucose Monitoring (CGM) devices, which are wearable medical technologies designed to provide continuous blood sugar readings. Addressing a specific need in veterinary medicine, ALR Technologies offers the GluCurve Pet CGM, tailored for diabetic felines and canines, and utilized by veterinarians. Furthermore, their Prediabetes System supports patients with educational video content, supplementary resources optimized for mobile devices, and a private online community for discussing disease management strategies. ALR Technologies primarily serves healthcare providers, health insurance companies, and entities specializing in disease and case management services, including those within the home care industry. Originally incorporated in 1987 as Mo Betta Corp., the company rebranded to ALR Technologies Inc. in December 1998. It is based in Richmond, Virginia, and operates as a subsidiary of ALR Technologies SG Ltd.
ALR Technologies Inc. is most often compared with the following Healthcare names: